Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Inventory (2016 - 2025)

Orthopediatrics has reported Inventory over the past 10 years, most recently at $133.8 million for Q4 2025.

  • Quarterly results put Inventory at $133.8 million for Q4 2025, up 14.35% from a year ago — trailing twelve months through Dec 2025 was $133.8 million (up 14.35% YoY), and the annual figure for FY2025 was $133.8 million, up 14.35%.
  • Inventory for Q4 2025 was $133.8 million at Orthopediatrics, up from $128.8 million in the prior quarter.
  • Over the last five years, Inventory for KIDS hit a ceiling of $133.8 million in Q4 2025 and a floor of $55.3 million in Q1 2021.
  • Median Inventory over the past 5 years was $95.8 million (2023), compared with a mean of $93.3 million.
  • Biggest five-year swings in Inventory: soared 35.82% in 2022 and later grew 6.27% in 2025.
  • Orthopediatrics' Inventory stood at $57.6 million in 2021, then skyrocketed by 35.82% to $78.2 million in 2022, then soared by 35.37% to $105.9 million in 2023, then rose by 10.54% to $117.0 million in 2024, then increased by 14.35% to $133.8 million in 2025.
  • The last three reported values for Inventory were $133.8 million (Q4 2025), $128.8 million (Q3 2025), and $125.3 million (Q2 2025) per Business Quant data.